PPARα deficiency does not modify age dependency but prevents high fat diet increase in plasma PAI-1 as well as insulin resistance

• References

• 1 Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor-1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 1991; 34: 457-2.
• 2 Banfi C, Mussoni L, Ris P. et al. Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type in cultured HepG2cells. Circ Res 1999; 85: 208-17.
• 3 Chen Y, Billadello JJ, Schneider DJ. Identification and localization of a fatty acid response region in the human plasminogen activator inhibitor-1 gene. Arterioscler Thromb Vase Biol 2000; 20: 2696-701.
• 4 Ihara H, Urano T, Takada A. et al. Induction of plasminogen activator inhibitor 1 gene expression in adipocytes by thiazolidinediones. FASEB J 2001; 15: 1233-5.
• 5 Nilsson L, Takemura T, Eriksson P. et al. Effects of fibrate compounds on expression of plasminogen activator inhibitor-1 by cultured endothelial cells. Arterioscler Thromb Vase Biol 1999; 19: 1577-81.
• 6 Kockx M, Princen HM, Kooistra T. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepato-cytes - role of the peroxisome proliferator-activated receptor-alpha. Thromb Haemost 1998; 80: 942-8.
• 7 Ye P, Hu X, Liu Y. et al. Activation of peroxisome proliferator-activated receptor alpha in human endothelial cells increases plasminogen activator inhibitor type-1 expression. Chin Med J 2003; 116: 29-33.
• 8 Guerre-Millo M, Rouault C, Poulain P. et al. PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance. Diabetes 2001; 50: 2809-14.
• 9 Declerck PJ, Verstreken M, Collen D. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice. Thromb Haemost 1995; 74: 1305-9.
• 10 Banfi C, Auwerx J, Poma F. et al. Induction of plasminogen activator inhibitor I by the PPA-Ralpha ligand, Wy-14,643, is dependent on ERK1/2 signaling pathway. Thromb Haemost 2003; 90: 611-9.
• 11 Tordjman K, Bernal-Mizrachi C, Zemany L. et al. PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice. J Clin Invest 2001; 107: 1025-34.
• 12 Guerre-Millo M, Gervois P, Raspe E. et al. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem 2000; 275: 16638-42.
• 13 Xu J, Xiao G, Trujillo C. et al. Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production. J Biol Chem 2002; 277: 50237-44.